Effects of 4-hydroxynonenal, a lipid peroxidation product, on dopamine transport and Na+/K+ ATPase in rat striatal synaptosomes

Neurochemistry International

Volumn 33, Issue 6, 1998, Pages 531-540

  Morel, P ^a   Tallineau, C ^a   Pontcharraud, R ^a   Piriou, A ^a   Huguet, F ^a  

^a UNIVERSITÉ DE POITIERS   (France)

Author keywords

4 Hydroxynonenal; Ascorbic acid; Dopamine uptake; Na+ K+ ATPase; Sulfhydryl groups; Synaptosomes

Indexed keywords

4 HYDROXYNONENAL; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ASCORBIC ACID; DOPAMINE; REACTIVE OXYGEN METABOLITE; THIOBARBITURIC ACID; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOL GROUP;

ARTICLE; BINDING AFFINITY; BRAIN SYNAPTOSOME; CONTROLLED STUDY; DOPAMINE UPTAKE; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN TISSUE; LIPID COMPOSITION; LIPID PEROXIDATION; MALE; MEMBRANE FLUIDITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN MODIFICATION; RAT; SODIUM TRANSPORT; SYNAPTIC TRANSMISSION;

ALDEHYDES; ANIMALS; ASCORBIC ACID; BIOLOGICAL TRANSPORT; CORPUS STRIATUM; DOPAMINE; LIPID PEROXIDATION; NA(+)-K(+)-EXCHANGING ATPASE; RATS; RATS, WISTAR; SULFHYDRYL COMPOUNDS; SYNAPTOSOMES; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 0032465098     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(98)00062-X     Document Type: Article

References (44)

1. Berman, S.B., Zigmond, M.J., Hastings T.G., 1996. Modification of dopamine transporter function: effect of reactive oxygen species and dopamine. J. Neurochem. 67, 593-600.
2. 3H] GBR 12783 specific binding during the maturation of rat striatum. Life Sci. 44, 1759-1765.
3. Borowsky, B., Hoffman, B.J., 1995. Neurotransmitter transporters: molecular biology, function, and regulation. International Rev. Neurobiol. 38, 139-199.
4. Bradford, M.N., 1976. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
5. Braughler, J.M., 1985. Lipid peroxidation-induced inhibition of γ-aminobutyric acid uptake in rat brain synaptosomes: protection by glucocorticoids. J. Neurochem. 44, 1282-1288.
6. Butterfield, D.A., Stadtman, E.R., 1997. Protein oxidation processes in aging brain. In: Mattson, M.P., Geddes, J.W. (Ed.), The aging brain. JAI Press, Greenwich, Connecticut (in press).
7. Cao, C.J., Youg, M.M., Wong, J.I.A.B., Mahran, L.G., Eldefrawi, M.E., 1989. Putative cocaine receptor in striatum is a glycoprotein with active thiol function. Membrane Biochem. 8, 207-220.
8. + ATPase by hydrostatic pressure studied with fluorescent probes. J. Biol. Chem. 260, 14480-14490.
9. Cook, E.Jr., Stein, M.A., Krasowski, M.D., Cox, N.J., Olkon, D.M., Kieffer, J.E., Leventhal, B.L., 1995. Association of attention-deficit disorder and the dopamine transporter gene. Am. J. Hum. Genet. 56, 993-998.
10. Davies, M.J., Forni, L.G., Willson, R.L., 1988. Vitamin E analogue Trolox C E.S.R. and pulse radiolysis studies of free radical reactions. Biochem. 255, 513-522.
11. Esterbauer, H., Schaur, R.J., Zollner, H., 1991. Chemistry and biochemistry of 4-hydroxynonenal, malonaledialdehyde and related aldehydes. Biol. Med. 11, 81-128.
12. Friguet, B., Stadman, E.R., Szweda, L.I., 1994. Modification of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. J. Biol. Chem. 269, 21639-21643.
13. Giros, B., Caron, M., 1993. Molecular characterization of the dopamine transporter. Trends Pharmacol. Sci. 14, 43-49.
14. Giros, B., El Mestikawy, S., Bertrand, L., Caron, M.G., 1991. Cloning and functional characterization of a cocaine-sensitive dopamine transporter. FEBS Lett. 295, 149-154.
15. Glowinski, J., Iversen, L.L., 1966. Regional studies of catecholamine in the rat brain. J. Neurochem. 13, 655-659.
16. Graham, D.G., 1978. Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol. Pharmacol. 14, 633-643.
17. 3H] dopamine: impact of ascorbic acid and glutathione. J. Neurochem. 63, 1126-1132.
18. Hirsch, E., Graybiel, A.M., Agid, Y., 1988. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 334, 345-348.
19. Holley, A.E., Walker, M.K., Cheeseman, K.H., Slater, T.F., 1993. Measurement of n-alkenals and hydroxyalkenals in biological samples. Free Radic. Biol. Med. 15, 281-289.
20. Innis, R.B., Seibyl, J.P., Scanley, B.E., Laruelle, M., Abidargham, A., Wallace, E., Baldwin, R.M., Zeaponce, Y., Zoghbi, S., Wang, S., Gao, Y., Neumeyer, J.L., Charney, D.S., Hoffer, P.B., Marek, K.L., 1993. Single-photon emission computed tomographic imaging demonstrated loss of striatal dopamine transporters in Parkinson's disease. Proc. Natl. Acad. Sci. USA 90; 11965-11969.
21. Jocelyn, P.C., 1987. Spectrophotometer Assay of Thiols. In: Jacoby W.B., Guffith O.W., (Eds.), Methods in Enzymology: Sulfur and Sulfur Amino Acids, Vol. 143. Academic Press, New York, pp. 44-67.
22. Jürgens, G., Lang, J., Esterbauer, H., 1986. Modification of human low density lipoprotein by the lipid peroxidation product 4-hydroxynonenal. Biochem. Biophys. Acta 875, 103-114.
23. Kilty, J.E., Lorang, D., Amara, S.G., 1991. Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science 254, 578-579.
24. Lesch, K.P., Bengel, D., 1995. Neurotransmitter reuptake mechanisms, targets for drugs to study and treat psychiatric, neurological and neurodegenerative disorders. CNS Drugs 4, 302-322.
25. Lester, H.A., Mager, S., Quick, M.W., Corey, J.L., 1994. Permeation properties of neurotransmitter transporters. Annu. Rev. Pharmacol. Toxicol. 34, 219-249.
26. Morel, P., Fauconneau, B., Page, G., Mirbeau, T., Huguet, F., 1998. Inhibitory effects of ascorbic acid on dopamine uptake by rat striatal synaptosomes: relationship to lipid peroxidation and oxidation of protein sulfhydryl groups. Neuroscience Res. (in press).
27. Nadkarni, D.V., Sayre, L.M., 1995. Structural definition of early lysine and histidine adduction chemistry of 4-hyroxynonenal. Chem. Res. Toxicol. 8, 284-291.
28. Patel, A., Boja, J.W., Lever, J., Lew, R., Simantov, R., Carroll, F.I., Lewin, A.H., Philip, A., Gao, Y., Kuhar, M.J., 1992. A cocaine analog and a GBR analog label the same protein in rat striatal membranes. Brain Res. 576, 173-174.
29. Perry, T.L., Godin, D.V., Hansen, S., 1982. Parkinson's disease: a disorder due to nigral glutathione deficiency? Neurosci. Lett. 33, 305-310.
30. 3H] dopamine uptake. Brain Res. 641, 83-91.
31. Pryor, W.A., Stanley, P., 1975. A suggested mechanism for the production of malonaledialdehyde during the autoxidation of polyunsaturated fatty acids. Nonenzymatic production of prostaglandin endoperoxides during autoxidation. J. Org. Chem. 40, 3615-3617.
32. Sandermann, H., 1978. Regulation of membrane enzymes by lipids. Biochem. Biophys. Acta 515, 209-237.
33. Shimada, S., Kitamaya, S., Lin, C.L., Patel, A., Nanthakumar, E., Gregor, P., Kuhar, M., Uhl, G., 1991. Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA. Science 254, 576-578.
34. + ATPase. Free Rad. Biol. Med. 20, 215-223.
35. 3H]-dopamine uptake by synaptic storage vesicles of rat whole brain and brain regions. Life Sci. 22, 823-830.
36. Sofic, E., Paulus, W., Jellinger, K., Riederer, P., Youdim, M.B.H., 1991. Selective increase in iron in substantia nigra zona compaeta of Parkinsonian brains. J. Neurochem. 56, 978-982.
37. Springer, J.E., Azbill, R.D., Mark, R.J., Begley, J.G., Waeg, G., Mattson, M.P., 1997. 4-Hydroxynonenal, a lipid peroxidation product, rapidly accumulates following traumatic spinal cord injury and inhibits glutamate uptake. J. Neurochem. 68, 2469-2476.
38. +)-stimulated ATPase in brain: separation, and difference in affinity for strophanthidin. J. Biol. Chem. 254, 6060-6067.
39. Tamura, H., Shibamoto, T., 1991. Gas chromatographic analysis of nonaldehyde and 4-hydroxy-2-(E)-nonenal produced from arachidonic and linoleic acid in a lipid peroxidation model system. Lipids 26, 170-173.
40. Uchida, K., Osawa, T., Hiai, H., Toyokuni, S., 1995. 4-Hydroxy-2-nonenal-trapping ELISA: direct evidence for the release of a cytotoxic aldehyde from oxidized low density lipoproteins. Biochem. Biophys. Res. Commun. 33, 12487-12494.
41. Viani, P., Zini, I., Cervato, G., Biagini, G., Aganti, L.F., Cestaro, B., 1991. Effect of endothelin-1 induced ischemia on peroxidative damage and membrane properties in rat striatum synaptosomes. Neurochem. Res. 20, 689-695.
42. Volterra, A., Trotti, D., Floridi, F., Racagni, G., 1994. Reactive oxygen species inhibit high-affinity glutamate uptake: Molecular mechanism and neuropathological implications. Ann. N.Y. Acad. Sci. 738, 153-162.
43. Wilbur, K.M., Bernheim, F., Shapiro, O.N., 1949. The thiobarbituric acid reagent as a test for the oxidation of unsaturated fatty acids by various agents. Arch. Biochem. 24, 305-313.
44. Yoshino, K., Sano, M., Fujita, M., Tomita, I., 1986. Formation of aldehydes in rat plasma and liver due to vitamin E deficiency. Free Rad. Biol. Med. 34, 5184-5187.